Brian Evanko compensation by year
Cigna Summary Compensation Table · all 5 fiscal years held| Component | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Salary | $800,000 | $836,731 | $923,077 | $994,231 | $1,073,077 |
| Bonus | $0 | $0 | $0 | $0 | $0 |
| Stock awards | $2,721,665 | $3,493,584 | $3,852,298 | $5,813,611 | $5,056,613 |
| Option awards | $840,007 | $1,078,170 | $1,296,909 | $1,725,052 | $1,650,055 |
| Non-equity incentive | $900,000 | $1,500,000 | $1,650,000 | $1,700,000 | $2,150,000 |
| Pension and deferred compensation | $0 | $0 | $15,415 | $0 | $14,810 |
| All other | $34,835 | $57,196 | $57,157 | $51,738 | $53,846 |
| Total | $5,296,507 | $6,965,681 | $7,794,856 | $10,284,632 | $9,998,401 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cigna Group DEF 14A filed March 13, 2026, accession 0001739940-26-000023, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 21,044 | $5,791,940 | — |
| PSU | 21,044 | $5,791,940 | — |
| RSU | 16,709 | $4,598,818 | — |
| PSU | 16,709 | $4,598,818 | — |
| Option | 19,158 | — | $305.86 |
| Option | 12,452 | — | $336.48 |
| Option | 5,423 | — | $294.61 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Cigna Group's FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2025 proxy (filed March 13, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-09-01 | Grant or award | — | 3,113 | $0.00 | 41,030 |
| 2026-09-01 | Grant or award derivative | — | 6,716 | $0.00 | 6,716 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Cigna’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Cordani | Chair and Chief Executive Officer | $22,866,134 |
| Eric Palmer | Former Executive Vice President, Enterprise Strategy, The Cigna Group, and President and Chief Executive Officer, Evernorth Health Services | $12,274,760 |
| Brian Evanko · this page | President and Chief Operating Officer | $9,998,401 |
| Nicole Jones | Executive Vice President, Chief Administrative Officer, and General Counsel | $5,955,936 |
| Ann Dennison | Executive Vice President, Chief Financial Officer | $4,691,526 |
| Noelle Eder | Former Executive Vice President, Global Chief Information Officer | $4,312,795 |
| Everett Neville | Executive Vice President, Strategy and Business Development | $4,073,915 |
The full Cigna compensation record
free company briefThis page is one person within Cigna's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Cigna's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Cigna's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat